Picture Berlin Partner Life Sciences Report 2019/2020 Brandenburg 650x80px
Organisation › Details

Ascendis Pharma (Group)

Period Start 2007-12-01 established
Products Industry TransCon technology
  Industry 2 pharmaceutical
Persons Person Mikkelsen, Jan (Ascendis Pharma 201609 CEO)
  Person 2 Smith, Scott T. (Ascendis Pharma 201609 CFO)
Region Region Hellerup
  Country Denmark
  Street 12 Tuborg Boulevard
  City 2900 Hellerup
  Tel +45-3694-4486
    Address record changed: 2020-12-02
Basic data Employees D: 101 to 500 (2017-12-31)
  Currency EUR
  Annual sales 1,530,000 (revenue, consolidated (2017) 2017-12-31)
  Profit -123,897,000 (2017-12-31)
  Cash 690,400,000 (2019-06-30)
Record changed: 2020-04-10


Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for Ascendis Pharma (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture EBD Group BIO-Europe Spring 2021 Digital 650x80

» top